PureTech Health plc

NASDAQ:PRTC

Biotechnology

Healthcare
$17.38 +2.64%

+$0.45 today

Market cap
$423.09M
Beta
0.79
P/E (TTM)
-0.4
EPS (TTM)
-$45.37
52W Low $14.50High $19.92

Volume 0.01M

Average 0.01M

PRTC Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

PureTech Health plcNASDAQ: PRTC

Weighted Avg Shares (Diluted) · Q4 FY2025 · quarter ended Dec 2025

Weighted avg shares (diluted) declines year over year

Q4 FY2025 weighted avg shares (diluted) of 2.41M shares fell 91.0% year over year. Over 3 fiscal years it compounded at -56.1% a year.

Context

  • Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
2.41M— QoQ
Last fiscal yearDec 2025
2.41M-91.1% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-91.0%——
1 year-91.1%——
3-year CAGR-56.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
2.41M USD
Year-over-year change
-91.1%
4-year CAGR
-46.2%

Weighted Avg Shares (Diluted) vs competitors

How PRTC compares with its peers on the latest reported figures

  • PRTC's FY2025 weighted avg shares (diluted) of 2.41M shares is the lowest of the 11 companies compared; the peer median is 127.02M shares.
  • Its year-over-year change of -91.1% is the lowest of 11, against a peer median of +24.8%.
  • Over three fiscal years its annual growth of -56.1% compares with a peer median of +17.9%.
PRTC Competitors Peer median
Weighted Avg Shares (Diluted) for PRTC and competitors
Company Period LTM YoY 3-year CAGR
AUTLAutolus Therapeutics plcLTM Mar 2026266.14M +0.0%+41.0%
LCTXLineage Cell Therapeutics, Inc.LTM Mar 2026237.13M +18.0%+10.7%
QSIQuantum-Si incorporatedLTM Mar 2026201.73M +31.6%+12.4%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026166.7M +4.0%+2.4%
ADCTADC Therapeutics S.A.LTM Mar 2026138.66M +34.3%+17.6%
ALMSAlumis Inc. Common StockLTM Jun 2026115.39M +93.6%+384.0%
RCKTRocket Pharmaceuticals, Inc.LTM Mar 2026111.46M +12.7%+17.7%
SLDBSolid Biosciences Inc.LTM Mar 202698.28M +94.3%+117.4%
BNTCBenitec Biopharma Inc.LTM Mar 202643.27M +112.6%+166.1%
NGNENeurogene Inc.LTM Mar 202620M +14.7%+18.2%
PRTCPureTech Health plcFY20252.41M -91.1%-56.1%
Peer median (excluding PRTC) 127.02M+24.8%+17.9%

Competitors are the stored peer set for PRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.98M2.09M3.33M4.83M4.66M
Cost of Revenue110.47M152.43M4.93M3.57M3.36M
Gross Profit(100.49M)(136.82M)(1.6M)1.26M4.66M
Gross Margin-1007.0%-6546.2%-48.1%26.0%100.0%
Research & Development81.52M116.11M96.24M54.28M45.74M
Selling, General & Admin30.76M35.67M48.36M27.49M20.65M
Operating Expenses160.26M60.99M54.55M140.41M103.18M
Depreciation & Amortization7.24M8.89M4.93M3.57M3.35M
EBITDA26.7M(188.91M)(11.63M)37.38M(61.8M)
EBITDA Margin267.6%-9038.9%-349.2%774.3%-1326.5%
Operating Income(150.28M)(197.81M)(146.2M)(136.1M)(98.53M)
Operating Margin-1506.0%-9464.4%-4390.4%-2818.9%-2114.7%
Interest Income214K5.8M16.01M22.67M13.05M
Interest Expense4.71M3.95M13.49M10.04M45.78M
Other Income / Expenses91.33M105.02M110.1M159.87M(12.4M)
Income Before Tax(58.95M)(92.78M)(36.1M)23.77M(110.93M)
Pre-Tax Margin-590.8%-4439.4%-1084.2%492.4%-2380.9%
Income Tax Expense3.76M(55.72M)30.53M(4.01M)(842K)
Net Income(60.56M)(50.36M)(65.7M)53.51M(109.74M)
Net Margin-606.9%-2409.3%-1972.9%1108.3%-2355.4%
EPS (Basic)(2.10)(1.80)(2.40)2.00(46.00)
EPS (Diluted)(2.10)(1.80)(2.40)2.00(46.00)
Weighted Avg Shares28.66M27.97M27.63M26.97M2.41M
Weighted Avg Shares (Diluted)28.66M28.48M27.63M26.97M2.41M

PureTech Health plc

NASDAQ:PRTC

Intrinsic Alpha fair value

Locked

Current Price

$17.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.